Cytology in differential diagnosis of histological types of NSCLC

J. Domagala-Kulawik, R. Krenke, R. Chazan (Warsaw, Poland)

Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Session: Biological and clinical markers in lung cancer
Session type: Thematic Poster Session
Number: 2679
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Domagala-Kulawik, R. Krenke, R. Chazan (Warsaw, Poland). Cytology in differential diagnosis of histological types of NSCLC. Eur Respir J 2009; 34: Suppl. 53, 2679

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS–FNA cytological samples
Source: Eur Respir J 2011; 38: 911-917
Year: 2011



The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


The diagnostic relevance of cytologic examination of induced sputum in lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 299s
Year: 2004

PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer
Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules
Year: 2018


Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


Bronchoscopic techniques in diagnosis and staging of lung cancer
Source: Breathe 2011; 7: 324-337
Year: 2011

Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens
Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017
Year: 2017



Bronchioalveolar lung carcinoma: its clinical, radiological and pathological features
Source: Eur Respir J 2006; 28: Suppl. 50, 90s
Year: 2006

Differential diagnostics of pulmonary TB and tumors in bronchial biopsy using cytologic methods
Source: Eur Respir J 2007; 30: Suppl. 51, 662s
Year: 2007

How do cytology samples compare with histology specimens when used for EGFR testing in patients with NSCLC?
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012


Clinical problems in diagnosis of lung carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 437s
Year: 2002

Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Current histological classification and staging of thymomas
Source: International Congress 2016 – PG20 Thymic tumours
Year: 2016



An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016

The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 74s
Year: 2002

Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




The value of sputum cytology in the diagnosis of lung malignancy
Source: Eur Respir J 2007; 30: Suppl. 51, 429s
Year: 2007

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis
Source: Eur Respir J 2008; 31: 854-859
Year: 2008



Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology
Source: Eur Respir Mon; 2010: 48: 272–296
Year: 2010

Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019